African farmers and healthcare workers are struggling to access malaria treatment, leading to severe consequences.

The International Livestock and Research Institute (ILRI), Kenya Medical Research Institute (KEMRI), and the Zoonotic Disease Unit are studying mosquito populations and disease transmission patterns to address the impact of climate change on malaria.

Heavy rainfall in the Horn of Africa has created breeding grounds for mosquitoes, increasing the risk of vector-borne diseases.

The World Health Organization (WHO) has reported an increase in malaria cases worldwide in 2022 compared to pre-pandemic levels.

In 2021, WHO endorsed the first malaria vaccine, RTS,S (Mosquirix), and a second vaccine, R21 Matrix M, was endorsed in 2022. Both vaccines are expected to be rolled out in African countries in 2024.